Cellular jakStat · target hub
JAK3 (JAK3)
JAK3 is a JAK kinase on the JAK-STAT signaling pathway axis. Validate with UniProt and literature. Indexed under "JAK family kinases" for antibodies and assay guidance.
| Type / example | Domain / context (brief) |
|---|---|
| Activating | Kinase/receptor activation |
| Fusion / amplification | Fusion or amplification (cohort-dependent) |
| CN gain | Copy gain and overexpression |
Naming and prevalence vary—annotate clinically with authoritative databases.
Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.
Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.
Overexpression vs endogenous JAK3 can differ in dosage, splicing, and compartmentation.
Adds JAK3 keyword bias atop the JAK-STAT 信号通路 antibody pool—if sparse, use presets above or global search.
This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.
Last reviewed: 2026-05-18
See the cellular jakStat hub for neighboring targets—cross-check PI3K, MAPK, and transmembrane transport pages as needed.